欢迎访问《中国临床药理学与治疗学》杂志官方网站,今天是

中国临床药理学与治疗学 ›› 1998, Vol. 3 ›› Issue (3): 161-164.

• •    下一篇

丁磺氨酸增强氮芥和环磷酰胺对肿瘤细胞的杀伤作用

张雪峰, 姚明辉   

  1. 上海医科大学基础医学药理教研室, 上海200032
  • 收稿日期:1998-04-24 发布日期:2020-12-02
  • 作者简介:张雪峰, 男, 29 岁, 硕士。姚明辉, 男, 教授, 教研室主任。

Enhancement of antitumor activity of nitrogen mustard and cyclophosphamide by buthionine sulfoximine in several cancer cell lines

ZHANG Xue-Feng, YAO Ming-Hui   

  1. Department of Pharmacology,School of Basic Medical Sciences, Shanghai Medical University,Shanghai 200032
  • Received:1998-04-24 Published:2020-12-02

摘要: 目的 的研究谷胱甘肽合成抑制剂丁磺氨酸(BSO)对氮芥及环磷酰胺体内外细胞毒作用的影响。方法 利用改良MTT 法及瘤体称重法检测化疗药对肿瘤细胞生长的抑制作用。结果 在体外BSO明显降低人HL-60白血病细胞中谷胱甘肽的含量, 并显著增强氮芥的细胞毒作用, 剂量修饰因子为9.19 。在体内BSO能增强环磷酰胺对小鼠Hepa A肝癌及Lewis肺癌的生长抑制作用, 抑制率分别由26.1%升至51.5%, 和由22.6%升至32.3%。结论 BSO 可增强氮芥和环磷酰胺对肿瘤细胞的体内外杀伤作用。

关键词: 丁磺氨酸, 氮芥, 环磷酰胺, 药物敏感性, 谷胱甘肽

Abstract: Aim To examine the effects of buthionine sulfoximine (BSO), a specific inhibitor of glutathione (GSH) synthesis, on the cytotoxicity of two alkylating agents nitrogen mustard (HN2) and cyclophosphamide (CTX) in three cancer cell lines in vitro and in vivo. Methods The cytotoxicity of drugs in vitro and in vivo was assessed by modified MTT assay and tumor-weight reduction respectively. Results In human leukaemia HL-60 cells,BSO (50 μmol·L-1) pretreatment resulted in marked depletion of cellular GSH (by 87% of control ofter 24 h) and enhanced cytotoxicity of HN2 (0.1 ~ 0.5 mg·L-1),with dosemodifying factor (DMF) of 9.19 observed. BSO (400, 500 mg·kg-1×7, po) and CTX (15, 17.5 mg·kg-1×7,ip) combination produced higher responses compared to CTX alone,with the growth inhibition rate increased from 22.6% to 32.3%, and from 26.1% to 51.1 % in Lewis- and Hepa A - tumoi-bearing mice respectively. Conclusion The cytotoxicity of HN2 and CTX can be enhanced by BSO in vitro and in vivo suggesting the clinical applicability of BSO as a new chemosensitizin agent.

Key words: buthionine sulfoximine, nitrogen mustard, cyclophosphamide, glutathione

中图分类号: